Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Olesja Eliseeva"'
Autor:
Maria Isaguliants, Olga Krotova, Stefan Petkov, Juris Jansons, Ekaterina Bayurova, Dzeina Mezale, Ilze Fridrihsone, Athina Kilpelainen, Philip Podschwadt, Yulia Agapkina, Olga Smirnova, Linda Kostic, Mina Saleem, Oleg Latyshev, Olesja Eliseeva, Anastasia Malkova, Tatiana Gorodnicheva, Britta Wahren, Ilya Gordeychuk, Elizaveta Starodubova, Anastasia Latanova
Publikováno v:
Microorganisms, Vol 9, Iss 6, p 1219 (2021)
Therapeutic DNA-vaccination against drug-resistant HIV-1 may hinder emergence and spread of drug-resistant HIV-1, allowing for longer successful antiretroviral treatment (ART) up-to relief of ART. We designed DNA-vaccines against drug-resistant HIV-1
Externí odkaz:
https://doaj.org/article/c917e04d846b4571aff6d1cd776891e0
Autor:
Juris Jansons, Ekaterina Bayurova, Dace Skrastina, Alisa Kurlanda, Ilze Fridrihsone, Dmitry Kostyushev, Anastasia Kostyusheva, Alexander Artyuhov, Erdem Dashinimaev, Darya Avdoshina, Alla Kondrashova, Vladimir Valuev-Elliston, Oleg Latyshev, Olesja Eliseeva, Stefan Petkov, Maxim Abakumov, Laura Hippe, Irina Kholodnyuk, Elizaveta Starodubova, Tatiana Gorodnicheva, Alexander Ivanov, Ilya Gordeychuk, Maria Isaguliants
Publikováno v:
Vaccines, Vol 8, Iss 2, p 318 (2020)
Telomerase reverse transcriptase (TERT) is a classic tumor-associated antigen overexpressed in majority of tumors. Several TERT-based cancer vaccines are currently in clinical trials, but immune correlates of their antitumor activity remain largely u
Externí odkaz:
https://doaj.org/article/3495d206e99b4ca59bdbc106e1fee4e5
Autor:
Juris Jansons, Irina Sominskaya, Natalia Petrakova, Elizaveta S. Starodubova, Olga A. Smirnova, Ekaterina Alekseeva, Ruta Bruvere, Olesja Eliseeva, Dace Skrastina, Elena Kashuba, Marija Mihailova, Sergey N. Kochetkov, Alexander V. Ivanov, Maria G. Isaguliants
Publikováno v:
Cells, Vol 8, Iss 3, p 208 (2019)
HCV core is an attractive HCV vaccine target, however, clinical or preclinical trials of core-based vaccines showed little success. We aimed to delineate what restricts its immunogenicity and improve immunogenic performance in mice. We designed plasm
Externí odkaz:
https://doaj.org/article/17bde8c3e2fd48d69f7ffa6d982df1aa
Autor:
Irina Sominskaya, Juris Jansons, Anastasija Dovbenko, Natalia Petrakova, Ilva Lieknina, Marija Mihailova, Oleg Latyshev, Olesja Eliseeva, Irina Stahovska, Inara Akopjana, Ivars Petrovskis, Maria Isaguliants
Publikováno v:
Journal of Immunology Research, Vol 2015 (2015)
Recent studies on the primate protection from HCV infection stressed the importance of immune response against structural viral proteins. Strong immune response against nucleocapsid (core) protein was difficult to achieve, requesting further experime
Externí odkaz:
https://doaj.org/article/a00746b2b7004a29ab635da9bd4e4aea
Autor:
Elizaveta Starodubova, Olga Krotova, David Hallengärd, Yulia Kuzmenko, Gunnel Engström, Diana Legzdina, Oleg Latyshev, Olesja Eliseeva, Anna Karin Maltais, Vera Tunitskaya, Vadim Karpov, Andreas Bråve, Maria Isaguliants
Publikováno v:
Molecular Imaging, Vol 11 (2012)
The efficient cell-mediated immune response clears cells expressing deoxyribonucleic acid (DNA) immunogens, but there are no methods to monitor this in vivo. We hypothesized that immune-mediated clearance can be monitored in vivo if DNA immunogens ar
Externí odkaz:
https://doaj.org/article/897be335bc7842948ed120a1e544abf8
Autor:
E G Altaeva, K P Alekseev, L. V. Kostina, Olesja Eliseeva, Grebennikova Tv, Oleg Latyshev, T. I. Aliper, K M Khametova, O.A. Verkhovsky
Publikováno v:
Problems of Virology. 64:156-164
Introduction . Rotovirus infection (RVI) caused by the dsRNA-containing virus from genus Rotavirus, Reoviridae family, belonging to group A (RVA), is the cause of severe diarrhea in human and other mammalian species. Vaccination is the most effective
Autor:
Alexander Artyuhov, Elizaveta Starodubova, Anastasia Kostyusheva, Maria G. Isaguliants, Vladimir T. Valuev-Elliston, E. B. Dashinimaev, Alla Kondrashova, Dace Skrastina, Irina Kholodnyuk, Ilya Gordeychuk, Olesja Eliseeva, Tatiana Gorodnicheva, Laura Hippe, Alexander V. Ivanov, Alisa Kurlanda, Darya Avdoshina, Oleg Latyshev, Dmitry Kostyushev, Ilze Fridrihsone, Juris Jansons, Stefan Petkov, Ekaterina Bayurova, Maxim A. Abakumov
Publikováno v:
Vaccines
Vaccines, Vol 8, Iss 318, p 318 (2020)
Volume 8
Issue 2
Vaccines, Vol 8, Iss 318, p 318 (2020)
Volume 8
Issue 2
Telomerase reverse transcriptase (TERT) is a classic tumor-associated antigen overexpressed in majority of tumors. Several TERT-based cancer vaccines are currently in clinical trials, but immune correlates of their antitumor activity remain largely u
Autor:
Oleg Latyshev, I. A. Zlatskiy, N. Y. Kulikova, T. V. Grebennikova, Anton Syroeshkin, M. A. Chichaeva, L. V. Kostina, E. V. Shubralova, A G Yuzhakov, Olesja Eliseeva, O. S. Tsygankov, M.A. Morozova
Publikováno v:
The Scientific World Journal, Vol 2018 (2018)
The Scientific World Journal
The Scientific World Journal
Cosmic dust samples from the surface of the illuminator of the International Space Station (ISS) were collected by a crew member during his spacewalk. The sampler with tampon in a vacuum container was delivered to the Earth. Washouts from the tampon
Autor:
Ivars Petrovskis, Natalia Petrakova, Oleg Latyshev, Juris Jansons, Maria G. Isaguliants, Irina Sominskaya, Ilva Lieknina, Marija Mihailova, Inara Akopjana, Irina Stahovska, Anastasija Dovbenko, Olesja Eliseeva
Publikováno v:
Journal of Immunology Research, Vol 2015 (2015)
Journal of Immunology Research
Journal of Immunology Research
Recent studies on the primate protection from HCV infection stressed the importance of immune response against structural viral proteins. Strong immune response against nucleocapsid (core) protein was difficult to achieve, requesting further experime
Autor:
Skrastina Dace, Paul Pumpen, Elena Kashuba, Elizaveta Starodubova, Olga A. Smirnova, Ruta Bruvere, Marija Mihailova, Irina Sominskaya, Olesja Eliseeva, Natalia Petrakova, Alexander V. Ivanov, Juris Jansons, Maria G. Isaguliants
Publikováno v:
Free Radical Biology and Medicine. 128:S105-S106
Hepatitis C virus (HCV) core protein is an attractive target for HCV vaccine, however little progress was achieved in trials. We aimed to delineate the factors restricting immunogenicity of HCV core, and to improve its performance as DNA immunogen in